Gene-determined hemocoagulation disease as a cause of ischemic stroke in children

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 111, Issue 12, 2011, Pages 3-9

  L'Vova, O A ^a   Kovtun, O P ^a   Chegodaev, D A ^a  

^a NONE

Author keywords

Children; Gene polymorphism; Stroke

Indexed keywords

ALPHA2 INTEGRIN; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ALLELE; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MUTATION; STROKE; THROMBOSIS;

ALLELES; BLOOD COAGULATION DISORDERS; CHILD; FEMALE; FIBRINOGEN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTEGRIN ALPHA2; MALE; MUTATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROKE; THROMBOSIS;

EID: 84865076629     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young «Management of Stroke in Infants and Children.A Scientific Statement From a SpecialWriting Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young». Stroke 2008; 39: 2644-2691.
2. Agnetti A., Carano N., Sani E. et al. Cryptogenic stroke in children: possible role of patent foramen ovale. Neuropediatrics 2006; 37: 53-56.
3. Bartz P.J., Cetta F., Cabalka A.K. et al. Paradoxical emboli in children and young adults: role of atrial septal defect and patent foramen ovale device closure. Mayo Clin Proc 2006; 81: 615-618.
4. Huidobro-Fernández B., Tolín-Hernani M.M., Vázquez-López M. et al. Arterial ischaemic stroke in children with cardiac diseases. RevNeurol 2009; 49: 5: 234-239.
5. Pavlakis S.G., Levinson K. Arterial ischemic stroke: common risk factors in newborns and children. Stroke 2009; 40: 79-81.
6. Launthier S., Carmant L., David M. et al. Stroke in children: The coexistence of multiple risk factors predicts poor outcome. Neurology 2000; 54: 371-378.
7. Lynch J.K., Hirtz D.G., DeVeber G., Nelson K.B. Report of the National Institute of Neurological Disorders and Stroke Workshop on Perinatal and Childhood Stroke. Pediatrics 2002; 109: 234-242.
8. Bonduel M., Sciuccati G., Hepner M. et al. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol 2003; 73: 81-86.
9. Kenet G., Lütkhoff L.K., Albisetti M., Bernard T. et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 2010; 121: 1838-1847.
10. Rotta N.T., Ranzan J. Ischemic stroke in children: a study of the associated alterations. Arquivos de Neuro-Psiquiatria 2004; 62: 618-625.
11. Kirkham F.J. Is there a genetic basis for pediatric stroke? Curr Opin Pediatr 2003; 15: 6: 547-558.
12. Furie K.L., Kasner S.E., Adams R.J. et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/American stroke association. Stroke 2011; 42: 1: 227-276.
13. Liu Y., Pan J., Wang S. et al. Beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients. Chin Med J 2002; 115: 214-216.
14. Steven P., Yvonne W.W., Janet Lee et al. Candidate Gene Polymorphisms Do Not Differ Between Newborns With Stroke and Normal Controls. Stroke 2006; 37: 2678.
15. Zenz W., Bodó Z., Plotho J. et al. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost 1998; 80: 763-766.
16. Roach E.S. Etiology of stroke in children. Semin Pediatr Neurol 2000; 7: 4: 244-260.
17. Mercuri E., Cowan F., Gupte G. et al. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. R{cyrillic}ediatrics 2001; 107: 6: 1400-1404.
18. Nowak-Göttl U., Kosch A., Schlegel N. Thromboembolism in newborns, infants and children. Thromb Haemost 2001; 86: 1: 464-474.
19. Nowak-Göttl U., Sträter R., Heinecke A. et al. Lipoprotein (a) and GeneticPolymorphisms of Clotting Factor V, Prothrombin, and Methylentetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood. Blood 1999; 94: 11: 3678-3682.
20. Lalouschek W., Schillinger M., Hsieh K. et al. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke 2005; 36: 7: 1405-1409.
21. Danckwardt S., Hentze M.W., Kulozik A.E. 3' end mRNA processing: olecularmechanisms and implications for health and disease. EMBO J 2008; 27: 482-498.
22. De Stefano V., Chiusolo P., Paciaroni K. et al. ProthrombinG20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998; 91: 10: 3562-3565.
23. Green D. Thrombophilia and stroke. Top Stroke Rehabil 2003; 10: 3: 21-33.
24. Akar N., Akar E., Deda G. et al. Co-existence of two prothrombotic mutations, factor V 1691 G-A and prothrombin gene 20210 G-A, and the risk of cerebral infarct in pediatric patients. Pediat Hematol Oncol 1999; 16: 565-566.
25. Bentolila S., Ripoll L., Drouet L. et al. Thrombophilia due to 20210 G-->A prothrombin polymorphism and cerebral ischemia in the young. Stroke 1997; 28: 9: 1846-1847.
26. Eriksson P., Kallin B., van 't Hooft F.M. et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995; 92: 6: 1851-1855.
27. Lijnen H.R. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2005; 3: 35-45.
28. Vaughan D.E. PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3: 1879-1883.
29. Attia J., Thakkinstian A., Wang Y. et al. The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study andmeta-analysis. J Stroke Cerebrovasc Dis 2007; 16: 4: 173-179.
30. Bivona G., Bellia C., Cammarieri S. et al. Plasminogen activator inhibitor- 1-675 4G/5G andmethylenetetrahydrofolate reductase gene variants in young acute myocardial infarction and juvenile ischemic stroke. Res J Biol Sci 2009; 3: 11: 1341-1343.
31. Laffan M.A. Fibrinogen polymorphisms and disease. Eur Heart J 2001; 22: 24: 2224-2226.
32. van't Hooft F.M., von Bahr S.J., Silveira A. et al. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 1999; 19: 12: 3063-3070.
33. Martiskainen M., Pohjasvaara T., Mikkelsson J. et al. Fibrinogen gene promoter-455 A allele as a risk factor for lacunar stroke. Stroke 2003; 34: 4: 886-891.
34. Ajzenberg N., Berroeta C., Philip I. et al. Association of the -92C/G and 807C/T polymorphisms of the alpha2 subunit gene with human platelets alpha2beta1 receptor density. Arterioscler Thromb Vasc Biol 2005; 25: 1756-1760.
35. Calvete J.J. Structures of integrin domains and concerted conformational changes in the bidirectional signaling mechanism of alphaIIbbeta3. Exp BiolMed (Maywood) 2004; 229: 8: 732-744.
36. Macchi L., Christiaens L., Brabant S. et al. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol 2003; 42: 6: 1115-1119.
37. McKee S.A., Sane D.C., Deliargyris E.N. Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thromb Haemost 2002; 88: 711-715.
38. Bray P.F. Platelet glycoprotein polymorphisms as a risk factor for thronbosis. Curr Opin Hematol 2000; 7: 5: 284-289.
39. Carlsson L.E., Santoso S., Spitzer C. et al. The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood 1999; 93: 11: 3583-3586.
40. Reiner A.P., Kumar P.N., Schwartz S.M. et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000; 31: 7: 1628-1633.
41. Zak I., Sarecka-Hujar B., Kopyta I. et al. The T Allele of the 677C>T olymorphism of Methylenetetrahydrofolate Reductase Gene is Associated With an Increased Risk of Ischemic Stroke in Polish Children. J ChildNeurol 2009; 24: 10: 1226-1262.
42. Catto A.J., Kohler H.P., Bannan S. et al. Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke 1998; 29: 4: 813-816.
43. Elbaz A., Poirier O., Canaple S. et al. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 2: 586-591.
44. Girelli D., Russo C., Ferraresi P., Olivieri O. Polymorphisms in the factor gene and the risk of myocardial infarction in the patients with coronary artery disease. N Engl JMed 2000; 14: 343: 11: 774-780.
45. Kohler H.P., Ariëns R.A., Whitaker P., Grant P.J. A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects crosslinking activity. Thromb Haemost 1998; 80: 4: 704.
46. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999; 81: 165-176.
47. Ganesan V., Prengler M., McShane M. et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003; 53: 167-173.
48. Kim O.J., Hong S.P., Ahn J.Y. et al. Influence of combined methionine synthase (MTR 2756A>G) andmethylenetetrahydrofolate reductase (MTHFR 677C>T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke. YonseiMed J 2007; 48: 2: 201-209.